The company has developed an advanced surgical system, called Pyrocarbon Implant Replacement (PIR), which offers minimally-invasive treatment for degenerative and arthritic knee disorders. Specifically designed to address cartilage defects in certain areas of the knee, the PIR consists of a single component with a hydroxylapatite coating for fixation. Moirai Orthopaedics is headquartered in Metairie, Louisiana.